Globesecure Tech (GSTL)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹43.95 |
| Market Cap | ₹70.05 Cr |
| P/E Ratio | 0 |
| ROCE | -4.85% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -470.83% |
| Debt/Equity | — |
| Sales Growth | -25.1% |
| Promoter Holding | 27.83% |
| 52-Week Range | ₹5.95 — ₹43.95 |
| Sector | IT - Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
First, I read the numbers as a business, not as a trading ticket. Globesecure Tech is an IT-enabled services company with sales of only ₹8 Cr in the latest quarter, and it lost ₹1 Cr on that revenue. The top line is shrinking 25.10% year-on-year, and profit growth is -470.83%. That is not a temporary blip; it is a business crying out for repair. A Piotroski F-score of 2/9 reinforces my caution. Healthy companies score much higher. At ₹23.24, the market cap is only ₹43 Cr, but with zero earnings, the P/E is meaningless. I cannot value it on price-to-book because no book value has been given, and the absence of debt/equity data makes it hard to know the real balance-sheet risk. ROCE is -4.85%, so the capital employed in this business is earning a negative return. A zero dividend means I am not being paid to wait. Promoter holding of 27.83% gives some skin in the game, but for a company this small I would want far more alignment. In Graham's terms, there is no margin of safety evident here. The 52-week range of ₹5.95 to ₹37.65 tells me the market has been speculative, not analytical. This may one day become a successful turnaround, but a great purchase requires a good business at a fair price, not just a low price. I need evidence that sales stabilise, losses narrow, and capital returns turn positive. Until then, I will watch from the sidelines.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer